SEC FORM 4
$9,287.78
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 2,006 shares at $4.63 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 7, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001839066-26-000054 · filed 2026-10-07 · View filing →